Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Alpha Teknova, Inc. (TKNO:NASDAQ), powered by AI.
Alpha Teknova, Inc. is currently trading at $4.96. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Alpha Teknova, Inc. on Alpha Lenz.
Alpha Teknova, Inc.'s P/E ratio is -15.4.
“Alpha Teknova, Inc. trades at a P/E of -15.4 (undervalued) with modest ROE of -22.8%.”
Ask for details →Alpha Teknova, Inc. is a biotechnology company that specializes in developing and manufacturing critical reagents and materials used in various stages of scientific research and production. Primarily serving the life sciences industry, the company's offerings include media and buffers, liquid-handling tools, and molecular components essential for laboratory assays and diagnostic tests. Alpha Teknova plays a crucial role in supporting pharmaceutical companies, diagnostics firms, and academic institutions, facilitating advancements in research and development. The company’s products are vital in applications such as cell culture, protein and nucleic acid detection, and high-throughput screening. By providing customized and high-quality solutions, Alpha Teknova helps optimize workflows in laboratories, thus accelerating innovation and discovery in the biotechnology sector. Through its contributions, the company is an integral part of the supply chain that underpins scientific breakthroughs and medical advancements.
“Alpha Teknova, Inc. trades at a P/E of -15.4 (undervalued) with modest ROE of -22.8%.”
Ask for details →Alpha Teknova, Inc. (ticker: TKNO) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 173 employees. Market cap is $265M.
The current price is $4.96 with a P/E ratio of -15.37x and P/B of 3.86x.
ROE is -22.83% and operating margin is -41.90%. Annual revenue is $41M.